NEW YORK (GenomeWeb News) – French diagnostics firm Theradiag and its collaborators in South Korea have been awarded a three-year grant from the European Commission to develop tests for rectal cancer based on microRNA and messenger RNA signatures, the company announced yesterday.

To read the full story....

Register for Free.

...and receive Daily News bulletins.

Already have an account?
Login Now.